News
To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.
The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.
5h
Vietnam Investment Review on MSNAscletis Unveils ASC47 Weight Loss Drug Candidate
Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouraging efficacy results from its study in diet-induced obese (DIO) mice combining ASC47, a first-in-class muscle-preserving weight loss drug ...
NVO has sector headwinds and product growth concerns. These problems don't have an easy solution and the market has ...
4h
TheHealthSite on MSNOzempic Side Effects: Active Ingredeints Found In Weight Loss Drugs Linked To Rare But Serious Eye Problems
A study published in JAMA Network, by the Case Western Reserve University examined about 15,11,637 eligible participants with ...
Despite posting record Q2 growth for its blockbuster weight loss and diabetes drug tirzepatide, Eli Lilly is facing legal ...
15h
India Today on MSNStudy links weight-loss drugs to serious eye conditions and vision loss
Weight-loss drugs Mounjaro and Wegovy gain popularity among Indian diabetes patients. New research highlights rare but ...
Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...
2h
Zacks.com on MSNNovo Nordisk Rises 6% So Far in August: How to Play the Stock
NVO stock climbs nearly 6% in August as Lilly's oral obesity candidate setback pivots investor sentiment toward the former's ...
Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to ...
WEIGHT loss drugs are still being brazenly flogged on the black market by a celebrity hairdresser who gave The Sun a Mounjaro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results